Suchergebnisse - "Oseltamivir"

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Autoren: Saubi N Andrés C Prats-Méndez I et al.

Körperschaften: Saubi N Andrés C Prats-Méndez I et al.

Quelle: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2025 Dec; Vol. 30 (48).

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/pharmacology , Oseltamivir*/therapeutic use , Influenza A Virus, H1N1 Subtype*/genetics , Influenza A Virus, H1N1 Subtype*/drug effects , Influenza A Virus, H1N1 Subtype*/isolation & purification , Influenza, Human*/virology , Influenza, Human*/epidemiology , Influenza, Human*/drug therapy , Antiviral Agents*/pharmacology , Antiviral Agents*/therapeutic use , Neuraminidase*/genetics , Drug Resistance, Viral*/genetics, Humans ; Europe/epidemiology ; Spain/epidemiology ; Mutation ; Microbial Sensitivity Tests

Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains.

Autoren: Khan WH Khan N Tembhre MK et al.

Quelle: Molecular diversity [Mol Divers] 2025 Dec; Vol. 29 (6), pp. 6481-6505. Date of Electronic Publication: 2025 Mar 14.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: ESCOM Science Publishers Country of Publication: Netherlands NLM ID: 9516534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-501X (Electronic) Linking ISSN: 13811991 NLM ISO Abbreviation: Mol Divers Subsets: MEDLINE

MeSH-Schlagworte: Neuraminidase*/genetics , Neuraminidase*/antagonists & inhibitors , Neuraminidase*/chemistry , Oseltamivir*/pharmacology , Oseltamivir*/chemistry , Drug Resistance, Viral*/genetics , Drug Resistance, Viral*/drug effects , Antiviral Agents*/pharmacology , Antiviral Agents*/chemistry , Mutation* , Influenza A Virus, H1N1 Subtype*/genetics , Influenza A Virus, H1N1 Subtype*/drug effects , Influenza A Virus, H1N1 Subtype*/enzymology , Enzyme Inhibitors*/pharmacology , Enzyme Inhibitors*/chemistry , Viral Proteins*/genetics , Viral Proteins*/antagonists & inhibitors , Viral Proteins*/chemistry, Molecular Docking Simulation ; Quantitative Structure-Activity Relationship ; Humans ; Molecular Dynamics Simulation ; Influenza, Human/virology ; Influenza, Human/drug therapy ; Drug Evaluation, Preclinical

The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.

Autoren: Feng X Yang X Hu X et al.

Quelle: Virology [Virology] 2025 Oct; Vol. 611, pp. 110642. Date of Electronic Publication: 2025 Jul 24.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0341 (Electronic) Linking ISSN: 00426822 NLM ISO Abbreviation: Virology Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/pharmacology , Oseltamivir*/therapeutic use , Antiviral Agents*/pharmacology , Antiviral Agents*/therapeutic use , Cytidine*/analogs & derivatives , Cytidine*/pharmacology , Cytidine*/therapeutic use , Orthomyxoviridae Infections*/drug therapy , Orthomyxoviridae Infections*/virology , Hydroxylamines*/pharmacology, Animals ; Mice ; Humans ; Dogs ; Influenza B virus/drug effects ; Influenza A Virus, H1N1 Subtype/drug effects ; Disease Models, Animal ; Madin Darby Canine Kidney Cells ; Drug Synergism ; Female ; Drug Therapy, Combination ; Mice, Inbred BALB C ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Influenza A virus/drug effects

Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024.

Autoren: Signore AV Joseph T Ranadheera C et al.

Quelle: Emerging microbes & infections [Emerg Microbes Infect] 2025 Dec; Vol. 14 (1), pp. 2469643. Date of Electronic Publication: 2025 Mar 11.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/pharmacology , Neuraminidase*/genetics , Influenza in Birds*/virology , Influenza in Birds*/epidemiology , Reassortant Viruses*/genetics , Reassortant Viruses*/drug effects , Reassortant Viruses*/isolation & purification , Drug Resistance, Viral*/genetics , Influenza A Virus, H5N1 Subtype*/genetics , Influenza A Virus, H5N1 Subtype*/drug effects , Influenza A Virus, H5N1 Subtype*/isolation & purification , Influenza A Virus, H5N1 Subtype*/classification , Antiviral Agents*/pharmacology , Poultry Diseases*/virology , Poultry Diseases*/epidemiology , Viral Proteins*/genetics, Animals ; Poultry/virology ; Phylogeny ; British Columbia/epidemiology ; Canada/epidemiology ; Mutation

Obesity in Recovery From Influenza-Like Illness and Effectiveness of Oseltamivir.

Autoren: Nguyen ON Garzón-Orjuela N van der Velden AW et al.

Quelle: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2025 Nov; Vol. 19 (11), pp. e70185.

Publikationsart: Journal Article; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/therapeutic use , Obesity*/complications , Influenza, Human*/drug therapy , Influenza, Human*/complications , Antiviral Agents*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Body Mass Index ; Aged ; Treatment Outcome ; Young Adult ; Severity of Illness Index

Efficacy of Mahuang Fuzi Xixin decoction combined with oseltamivir and ribavirin for aged patients with viral flu during the recent influenza pandemic in Mainland China: A randomized controlled trial.

Autoren: Yu M Zu PZ Guo LY et al.

Quelle: Medicine [Medicine (Baltimore)] 2025 Oct 31; Vol. 104 (44), pp. e45604.

Publikationsart: Journal Article; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

MeSH-Schlagworte: Influenza, Human*/drug therapy , Influenza, Human*/epidemiology , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Drugs, Chinese Herbal*/therapeutic use , Drugs, Chinese Herbal*/administration & dosage , Oseltamivir*/therapeutic use , Oseltamivir*/administration & dosage , Ribavirin*/therapeutic use , Ribavirin*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; China/epidemiology ; Aged ; Drug Therapy, Combination ; Treatment Outcome ; Pandemics

Single-Dose Oral Influenza Antiviral Prodrug Enabled by Cholesterol Conjugation.

Autoren: Li C Lv X Cheng C et al.

Quelle: Journal of medicinal chemistry [J Med Chem] 2025 Oct 23; Vol. 68 (20), pp. 21577-21586. Date of Electronic Publication: 2025 Oct 03.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

MeSH-Schlagworte: Prodrugs*/administration & dosage , Prodrugs*/chemistry , Prodrugs*/pharmacology , Prodrugs*/pharmacokinetics , Prodrugs*/therapeutic use , Antiviral Agents*/administration & dosage , Antiviral Agents*/pharmacology , Antiviral Agents*/chemistry , Antiviral Agents*/pharmacokinetics , Antiviral Agents*/therapeutic use , Cholesterol*/chemistry , Oseltamivir*/administration & dosage , Oseltamivir*/analogs & derivatives , Oseltamivir*/pharmacokinetics , Oseltamivir*/pharmacology , Oseltamivir*/therapeutic use , Oseltamivir*/chemistry , Orthomyxoviridae Infections*/drug therapy, Animals ; Administration, Oral ; Mice ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/drug effects ; Humans ; Mice, Inbred BALB C ; Female

Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood.

Autoren: Hastings LE Acosta EP Kimberlin DW

Quelle: The Journal of infectious diseases [J Infect Dis] 2025 Oct 17; Vol. 232 (Supplement_3), pp. S286-S298.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

MeSH-Schlagworte: Antiviral Agents*/pharmacokinetics , Antiviral Agents*/pharmacology , Antiviral Agents*/therapeutic use , Influenza, Human*/drug therapy , Oseltamivir*/pharmacokinetics , Oseltamivir*/pharmacology , Oseltamivir*/therapeutic use , Pregnancy Complications, Infectious*/drug therapy, Humans ; Pregnancy ; Female ; Infant ; Child, Preschool ; Dibenzothiepins/pharmacokinetics ; Pyridones/pharmacokinetics ; Morpholines/pharmacokinetics ; Triazines/pharmacokinetics ; Triazines/pharmacology ; Triazines/therapeutic use ; Thiepins/pharmacokinetics ; Thiepins/pharmacology ; Thiepins/therapeutic use ; Pyridines/pharmacokinetics ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Infant, Newborn ; Neuraminidase/antagonists & inhibitors

Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?

Autoren: Lee K Pavia AT Englund JA

Quelle: The Journal of infectious diseases [J Infect Dis] 2025 Oct 17; Vol. 232 (Supplement_3), pp. S327-S332.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/therapeutic use , Influenza, Human*/drug therapy , Influenza, Human*/diagnosis , Antiviral Agents*/therapeutic use , Nonprescription Drugs*/therapeutic use , Health Services Accessibility*, Humans

Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents.

Autoren: Antoon JW Williams DJ Bruce J et al.

Quelle: JAMA neurology [JAMA Neurol] 2025 Oct 01; Vol. 82 (10), pp. 1013-1021.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/adverse effects , Oseltamivir*/therapeutic use , Influenza, Human*/drug therapy , Influenza, Human*/epidemiology , Antiviral Agents*/adverse effects , Antiviral Agents*/therapeutic use , Mental Disorders*/chemically induced , Mental Disorders*/epidemiology, Humans ; Child ; Adolescent ; Female ; Male ; Child, Preschool ; Retrospective Studies ; Cohort Studies ; Tennessee/epidemiology

Characterization and bioevaluation of radioiodinated oseltamivir phosphate for inflammation imaging as a new perspective.

Autoren: Challan SB Abd El-Kareem MSM Rashad AM et al.

Quelle: Bioorganic chemistry [Bioorg Chem] 2025 Oct; Vol. 165, pp. 109050. Date of Electronic Publication: 2025 Sep 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/chemistry , Oseltamivir*/pharmacology , Oseltamivir*/analogs & derivatives , Oseltamivir*/chemical synthesis , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/chemistry , Anti-Bacterial Agents*/chemical synthesis , Inflammation*/diagnostic imaging , Radiopharmaceuticals*/chemistry , Radiopharmaceuticals*/pharmacology , Radiopharmaceuticals*/chemical synthesis, Staphylococcus aureus/drug effects ; Animals ; Iodine Radioisotopes/chemistry ; Microbial Sensitivity Tests ; Mice ; Molecular Structure ; Dose-Response Relationship, Drug

Efficacy of Oseltamivir Against Seasonal Influenza H1N1 and the Efficacy of a Novel Combination Treatment In Vitro and In Vivo in Mouse Studies.

Autoren: Liu D Leung KY Zhang R et al.

Quelle: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2025 Oct; Vol. 19 (10), pp. e70176.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/pharmacology , Oseltamivir*/administration & dosage , Oseltamivir*/therapeutic use , Influenza A Virus, H1N1 Subtype*/drug effects , Influenza A Virus, H1N1 Subtype*/genetics , Influenza A Virus, H1N1 Subtype*/physiology , Antiviral Agents*/pharmacology , Antiviral Agents*/administration & dosage , Antiviral Agents*/therapeutic use , Orthomyxoviridae Infections*/drug therapy , Orthomyxoviridae Infections*/virology, Animals ; Mice ; Virus Replication/drug effects ; Triazines/pharmacology ; Triazines/administration & dosage ; Triazines/therapeutic use ; Dibenzothiepins ; Drug Therapy, Combination ; Disease Models, Animal ; Humans ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Pyridones/pharmacology ; Female ; Thiourea/analogs & derivatives ; Thiourea/pharmacology ; Thiourea/administration & dosage ; Thiourea/therapeutic use ; Morpholines ; Hydroxylamines/pharmacology ; Mice, Inbred BALB C ; Lung/pathology ; Lung/virology ; Pyridines/pharmacology ; Drug Resistance, Viral ; Cytidine/analogs & derivatives

Antileishmanial Activity of Oseltamivir and Acyclovir: Modulation of Macrophage Phagocytosis and Cytotoxicity Assessment.

Autoren: Lima Neta PP Leal PPMS Passos VHAA et al.

Quelle: Anais da Academia Brasileira de Ciencias [An Acad Bras Cienc] 2025 Oct 20; Vol. 97 (4), pp. e20250377. Date of Electronic Publication: 2025 Oct 20 (Print Publication: 2025).

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Academia Brasileira De Ciencias Country of Publication: Brazil NLM ID: 7503280 Publication Model: eCollection Cited Medium: Internet ISSN: 1678-2690 (Electronic) Linking ISSN: 00013765 NLM ISO Abbreviation: An Acad Bras Cienc Subsets: MEDLINE

MeSH-Schlagworte: Phagocytosis*/drug effects , Acyclovir*/pharmacology , Macrophages*/drug effects , Macrophages*/parasitology , Oseltamivir*/pharmacology , Antiprotozoal Agents*/pharmacology , Leishmania*/drug effects , Leishmania*/classification, Inhibitory Concentration 50 ; Animals ; Mice ; Antiviral Agents/pharmacology

Associations of oseltamivir with neuropsychiatric and behavioral adverse events: A systematic review and meta-analysis.

Autoren: Jeong HS Lee YW Rhee TG et al.

Quelle: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2025 Oct; Vol. 31 (10), pp. 1051-1061.

Publikationsart: Journal Article; Systematic Review; Meta-Analysis

Info zur Zeitschrift: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/adverse effects , Antiviral Agents*/adverse effects , Mental Disorders*/chemically induced , Mental Disorders*/epidemiology , Influenza, Human*/drug therapy, Humans ; Suicide, Attempted/statistics & numerical data

Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters.

Autoren: Mehta D Fairman K Li M et al.

Quelle: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2026 Jan; Vol. 164, pp. 105979. Date of Electronic Publication: 2025 Oct 22.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/pharmacokinetics , Oseltamivir*/administration & dosage , Oseltamivir*/analogs & derivatives , Oseltamivir*/blood , Antiviral Agents*/pharmacokinetics , Antiviral Agents*/administration & dosage , Antiviral Agents*/blood , Models, Biological*, Animals ; Female ; Pregnancy ; Macaca mulatta ; Pregnancy Trimesters/metabolism

Oseltamivir Phosphate Modulates CD24-Siglec-G/10 Interaction to Suppress Microglial-Driven Neuroinflammation After Cardiac Arrest.

Autoren: Chen Y Liu Y Li N et al.

Quelle: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2025 Aug; Vol. 31 (8), pp. e70495.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium: Internet ISSN: 1755-5949 (Electronic) Linking ISSN: 17555930 NLM ISO Abbreviation: CNS Neurosci Ther Subsets: MEDLINE

MeSH-Schlagworte: Microglia*/drug effects , Microglia*/metabolism , CD24 Antigen*/metabolism , CD24 Antigen*/drug effects , Heart Arrest*/metabolism , Heart Arrest*/drug therapy , Heart Arrest*/complications , Oseltamivir*/pharmacology , Oseltamivir*/therapeutic use , Neuroinflammatory Diseases*/drug therapy , Neuroinflammatory Diseases*/metabolism , Neuroinflammatory Diseases*/etiology, Animals ; Male ; Swine ; Cardiopulmonary Resuscitation

Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

Autoren: Lewis NM Harker EJ Grant LB et al.

Körperschaften: Lewis NM Harker EJ Grant LB et al.

Quelle: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Aug 01; Vol. 81 (1), pp. 190-197.

Publikationsart: Journal Article; Observational Study; Multicenter Study

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

MeSH-Schlagworte: Oseltamivir*/therapeutic use , Oseltamivir*/administration & dosage , Influenza, Human*/drug therapy , Influenza, Human*/mortality , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Prospective Studies ; Hospitalization ; Influenza A virus/drug effects ; United States/epidemiology ; Young Adult ; Sentinel Surveillance ; Hospital Mortality ; Aged, 80 and over

Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza.

Autoren: Jiang J Wang J Hou W et al.

Quelle: Microbiology spectrum [Microbiol Spectr] 2025 Jul; Vol. 13 (7), pp. e0295424. Date of Electronic Publication: 2025 May 22.

Publikationsart: Journal Article; Multicenter Study; Comparative Study

Info zur Zeitschrift: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

MeSH-Schlagworte: Antiviral Agents*/therapeutic use , Dibenzothiepins*/therapeutic use , Influenza, Human*/drug therapy , Influenza, Human*/virology , Kidney Transplantation*/adverse effects , Oseltamivir*/therapeutic use , Oxazines*/therapeutic use , Thiepins*/therapeutic use, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; China ; Morpholines/therapeutic use ; Pyridones/therapeutic use ; Retrospective Studies ; Transplant Recipients ; Treatment Outcome ; Triazines/therapeutic use

Topical formulation of Oseltamivir promotes clinical improvement and reduction of parasite load in BALB/c mice infected with Leishmaniamajor.

Autoren: Passos VHAA Leal PPMS Lima Neta PP et al.

Quelle: Experimental parasitology [Exp Parasitol] 2025 Jul; Vol. 274, pp. 108966. Date of Electronic Publication: 2025 May 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Academic Press Country of Publication: United States NLM ID: 0370713 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2449 (Electronic) Linking ISSN: 00144894 NLM ISO Abbreviation: Exp Parasitol Subsets: MEDLINE

MeSH-Schlagworte: Leishmaniasis, Cutaneous*/drug therapy , Leishmaniasis, Cutaneous*/pathology , Leishmaniasis, Cutaneous*/parasitology , Oseltamivir*/administration & dosage , Oseltamivir*/therapeutic use , Leishmania major*/drug effects , Antiprotozoal Agents*/therapeutic use , Antiprotozoal Agents*/administration & dosage , Antiviral Agents*/administration & dosage , Antiviral Agents*/therapeutic use, Animals ; Mice, Inbred BALB C ; Mice ; Parasite Load ; Female ; Amphotericin B/therapeutic use ; Amphotericin B/administration & dosage ; Administration, Topical ; Drug Therapy, Combination ; Liver/pathology ; Liver/drug effects ; Emulsions

Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models.

Autoren: Fage C Loison S Zwygart AC et al.

Quelle: Antiviral research [Antiviral Res] 2025 Jul; Vol. 239, pp. 106174. Date of Electronic Publication: 2025 May 03.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

MeSH-Schlagworte: Drug Resistance, Viral* , Oseltamivir*/pharmacology , Antiviral Agents*/pharmacology , Triazines*/pharmacology , Dibenzothiepins*/pharmacology , Influenza A Virus, H1N1 Subtype*/drug effects , Thiepins*/pharmacology , Pyridines*/pharmacology, Animals ; Humans ; Mice ; Morpholines/pharmacology ; Pyridones/pharmacology ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/virology ; Disease Models, Animal ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Drug Therapy, Combination ; N-Acetylneuraminic Acid/pharmacology ; Female ; Respiratory Mucosa/virology